SCHEMBL29375231

SCHEMBL29375231

C[Si](C)(C)C#Cc1cc(F)c(O)c(C=O)c1

nearest known ligand 0.50

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 20/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22465884 1.00 ERN1 (0.50) ERN1
SCHEMBL12767670 0.79 ERN1 (0.61) ERN1
SCHEMBL1165175 0.78 ERN1 (0.35) ERN1
SCHEMBL411743 0.75 ERN1 (0.58) ERN1
SCHEMBL29384703 0.75 ERN1 (0.58) ERN1
SCHEMBL22466223 0.75 ERN1 (0.58) ERN1
SCHEMBL30362870 0.74 ERN1 (0.58) ERN1
SCHEMBL7526965 0.72 LOX (0.31)
SCHEMBL20455582 0.71 ERN1 (0.32) ERN1
SCHEMBL19677742 0.70 HDAC1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114025847-B Compounds and compositions as modulators of TLR signaling 神经孔疗法股份有限公司 2024-05-24 CN disclosed
EP-3946599-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING Neuropore Therapies, Inc. (US) 2022-02-09 EP disclosed
CN-114025847-A Compounds and compositions as modulators of TLR signaling 神经孔疗法股份有限公司 2022-02-08 CN disclosed